| Schedule of Earnings Per Share Basic and Diluted |
Schedule
of Earnings Per Share Basic and Diluted
| |
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
| |
|
Three
Months Ended March 31, |
|
|
Six
Months Ended March 31, |
|
| |
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
| Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net income
(loss) |
|
$ |
365,425 |
|
|
$ |
(5,667,071 |
) |
|
$ |
(803,084 |
) |
|
$ |
(11,209,213 |
) |
| Denominator: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Weighted average shares outstanding, basic |
|
|
4,617,665 |
|
|
|
750,582 |
|
|
|
4,205,469 |
|
|
|
530,131 |
|
| Restricted stock units
and awards |
|
|
11,154 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Warrants |
|
|
257,026 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Weighted average shares outstanding, diluted |
|
|
4,885,845 |
|
|
|
750,582 |
|
|
|
4,205,469 |
|
|
|
530,131 |
|
| Net income (loss) per share, basic |
|
$ |
0.08 |
|
|
$ |
(7.55 |
) |
|
$ |
(0.19 |
) |
|
$ |
(21.14 |
) |
| Net income (loss) per share, diluted |
|
$ |
0.07 |
|
|
$ |
(7.55 |
) |
|
$ |
(0.19 |
) |
|
$ |
(21.14 |
) |
|
| Schedule of Potentially Dilutive Securities |
The
following potentially dilutive securities have been excluded from the computation of diluted shares of common stock outstanding as they
would be anti-dilutive:
Schedule of Potentially Dilutive Securities
| |
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
| |
|
Three
Months Ended March 31, |
|
|
Six
Months Ended March 31, |
|
| |
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
| Common stock warrants August 2021 |
|
|
112,429 |
|
|
|
128,500 |
|
|
|
112,429 |
|
|
|
128,500 |
|
| Underwriter warrants August 2021 |
|
|
2,287 |
|
|
|
2,287 |
|
|
|
2,287 |
|
|
|
2,287 |
|
| Chanticleer warrants |
|
|
57 |
|
|
|
57 |
|
|
|
57 |
|
|
|
57 |
|
| Series C warrants |
|
|
18,391 |
|
|
|
36,778 |
|
|
|
18,391 |
|
|
|
36,778 |
|
| Series 3 warrants |
|
|
12,548 |
|
|
|
12,548 |
|
|
|
12,548 |
|
|
|
12,548 |
|
| Unvested restricted stock units and awards |
|
|
— |
|
|
|
7,840 |
|
|
|
137,259 |
|
|
|
7,840 |
|
| Common stock warrants February 2023 |
|
|
271,883 |
|
|
|
1,241,575 |
|
|
|
271,883 |
|
|
|
1,241,575 |
|
| Underwriter warrants February 2023 |
|
|
15,466 |
|
|
|
44,190 |
|
|
|
15,466 |
|
|
|
44,190 |
|
| Common stock private placement warrants June
2023 |
|
|
227,272 |
|
|
|
— |
|
|
|
227,272 |
|
|
|
— |
|
| Placement agent warrants June 2023 |
|
|
6,818 |
|
|
|
— |
|
|
|
6,818 |
|
|
|
— |
|
| Common stock warrants October 2023 |
|
|
— |
|
|
|
— |
|
|
|
5,652,500 |
|
|
|
— |
|
| Underwriter warrants October 2023 |
|
|
85,312 |
|
|
|
— |
|
|
|
85,312 |
|
|
|
— |
|
| Total
anti-dilutive weighted average shares |
|
|
752,463 |
|
|
|
1,473,775 |
|
|
|
6,542,222 |
|
|
|
1,473,775 |
|
|